nodes	percent_of_prediction	percent_of_DWPC	metapath
Simvastatin—ABCB1—ovarian cancer	0.175	1	CbGaD
Simvastatin—SLCO1A2—Chlorambucil—ovarian cancer	0.121	0.212	CbGbCtD
Simvastatin—UGT2B7—Epirubicin—ovarian cancer	0.0662	0.116	CbGbCtD
Simvastatin—ABCC2—Paclitaxel—ovarian cancer	0.0343	0.0604	CbGbCtD
Simvastatin—ABCC2—Carboplatin—ovarian cancer	0.0323	0.0568	CbGbCtD
Simvastatin—ABCC2—Docetaxel—ovarian cancer	0.0248	0.0437	CbGbCtD
Simvastatin—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0229	0.0403	CbGbCtD
Simvastatin—CYP3A7—Paclitaxel—ovarian cancer	0.0229	0.0403	CbGbCtD
Simvastatin—ABCB1—Topotecan—ovarian cancer	0.0226	0.0398	CbGbCtD
Simvastatin—ABCC2—Doxorubicin—ovarian cancer	0.0185	0.0326	CbGbCtD
Simvastatin—CYP3A5—Paclitaxel—ovarian cancer	0.0172	0.0303	CbGbCtD
Simvastatin—CYP3A7—Docetaxel—ovarian cancer	0.0166	0.0292	CbGbCtD
Simvastatin—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0166	0.0292	CbGbCtD
Simvastatin—CYP2C8—Paclitaxel—ovarian cancer	0.0165	0.0291	CbGbCtD
Simvastatin—ABCB1—Vinorelbine—ovarian cancer	0.0159	0.028	CbGbCtD
Simvastatin—CYP2D6—Vinorelbine—ovarian cancer	0.015	0.0264	CbGbCtD
Simvastatin—CYP3A4—Topotecan—ovarian cancer	0.0135	0.0238	CbGbCtD
Simvastatin—CYP3A5—Docetaxel—ovarian cancer	0.0124	0.0219	CbGbCtD
Simvastatin—CYP2B6—Doxorubicin—ovarian cancer	0.0118	0.0207	CbGbCtD
Simvastatin—CYP2C9—Paclitaxel—ovarian cancer	0.0115	0.0203	CbGbCtD
Simvastatin—ABCB1—Paclitaxel—ovarian cancer	0.0112	0.0197	CbGbCtD
Simvastatin—CYP3A4—Vinorelbine—ovarian cancer	0.00954	0.0168	CbGbCtD
Simvastatin—ABCB1—Docetaxel—ovarian cancer	0.00809	0.0142	CbGbCtD
Simvastatin—CYP3A4—Paclitaxel—ovarian cancer	0.0067	0.0118	CbGbCtD
Simvastatin—ABCB1—Doxorubicin—ovarian cancer	0.00603	0.0106	CbGbCtD
Simvastatin—CYP2D6—Doxorubicin—ovarian cancer	0.00568	0.01	CbGbCtD
Simvastatin—CYP3A4—Docetaxel—ovarian cancer	0.00484	0.00853	CbGbCtD
Simvastatin—CYP3A4—Doxorubicin—ovarian cancer	0.00361	0.00636	CbGbCtD
Simvastatin—ITGB2—epithelium—ovarian cancer	0.00306	0.0621	CbGeAlD
Simvastatin—ITGB2—uterine cervix—ovarian cancer	0.00304	0.0615	CbGeAlD
Simvastatin—ITGB2—decidua—ovarian cancer	0.00289	0.0586	CbGeAlD
Simvastatin—ITGB2—uterus—ovarian cancer	0.00253	0.0513	CbGeAlD
Simvastatin—ITGB2—female reproductive system—ovarian cancer	0.00228	0.0461	CbGeAlD
Simvastatin—ITGB2—bone marrow—ovarian cancer	0.00215	0.0435	CbGeAlD
Simvastatin—ITGB2—female gonad—ovarian cancer	0.00207	0.0419	CbGeAlD
Simvastatin—ITGB2—vagina—ovarian cancer	0.00206	0.0417	CbGeAlD
Simvastatin—ITGB2—testis—ovarian cancer	0.00184	0.0372	CbGeAlD
Simvastatin—HMGCR—myometrium—ovarian cancer	0.00139	0.0282	CbGeAlD
Simvastatin—ITGB2—lymph node—ovarian cancer	0.00133	0.027	CbGeAlD
Simvastatin—UGT2B7—female reproductive system—ovarian cancer	0.0011	0.0223	CbGeAlD
Simvastatin—HMGCR—epithelium—ovarian cancer	0.00109	0.0222	CbGeAlD
Simvastatin—HMGCR—uterine cervix—ovarian cancer	0.00108	0.022	CbGeAlD
Simvastatin—HMGCR—decidua—ovarian cancer	0.00103	0.0209	CbGeAlD
Simvastatin—HMGCR—endometrium—ovarian cancer	0.000981	0.0199	CbGeAlD
Simvastatin—HMGCR—gonad—ovarian cancer	0.00091	0.0184	CbGeAlD
Simvastatin—HMGCR—uterus—ovarian cancer	0.000904	0.0183	CbGeAlD
Simvastatin—UGT2B7—testis—ovarian cancer	0.000888	0.018	CbGeAlD
Simvastatin—HMGCR—female reproductive system—ovarian cancer	0.000812	0.0165	CbGeAlD
Simvastatin—SLCO1B1—female reproductive system—ovarian cancer	0.000778	0.0158	CbGeAlD
Simvastatin—HMGCR—bone marrow—ovarian cancer	0.000767	0.0155	CbGeAlD
Simvastatin—HMGCR—female gonad—ovarian cancer	0.000739	0.015	CbGeAlD
Simvastatin—HMGCR—vagina—ovarian cancer	0.000735	0.0149	CbGeAlD
Simvastatin—HMGCR—testis—ovarian cancer	0.000656	0.0133	CbGeAlD
Simvastatin—Lovastatin—ABCB1—ovarian cancer	0.000651	0.5	CrCbGaD
Simvastatin—Pravastatin—ABCB1—ovarian cancer	0.000651	0.5	CrCbGaD
Simvastatin—ABCC2—female reproductive system—ovarian cancer	0.00059	0.012	CbGeAlD
Simvastatin—CYP2C8—endometrium—ovarian cancer	0.000534	0.0108	CbGeAlD
Simvastatin—CYP3A5—uterine cervix—ovarian cancer	0.000533	0.0108	CbGeAlD
Simvastatin—SLCO1A2—testis—ovarian cancer	0.000511	0.0104	CbGeAlD
Simvastatin—ABCC2—testis—ovarian cancer	0.000476	0.00965	CbGeAlD
Simvastatin—HMGCR—lymph node—ovarian cancer	0.000475	0.00963	CbGeAlD
Simvastatin—CYP2C19—vagina—ovarian cancer	0.000459	0.00929	CbGeAlD
Simvastatin—CYP2B6—gonad—ovarian cancer	0.000444	0.009	CbGeAlD
Simvastatin—CYP2C8—female reproductive system—ovarian cancer	0.000443	0.00897	CbGeAlD
Simvastatin—CYP2C8—vagina—ovarian cancer	0.0004	0.00811	CbGeAlD
Simvastatin—CYP2B6—female reproductive system—ovarian cancer	0.000397	0.00804	CbGeAlD
Simvastatin—CYP2C9—female reproductive system—ovarian cancer	0.000393	0.00796	CbGeAlD
Simvastatin—ABCB1—myometrium—ovarian cancer	0.000364	0.00737	CbGeAlD
Simvastatin—CYP3A5—female gonad—ovarian cancer	0.000363	0.00736	CbGeAlD
Simvastatin—CYP3A5—vagina—ovarian cancer	0.000361	0.00732	CbGeAlD
Simvastatin—CYP2B6—vagina—ovarian cancer	0.000359	0.00727	CbGeAlD
Simvastatin—CYP2C8—testis—ovarian cancer	0.000357	0.00724	CbGeAlD
Simvastatin—ABCB1—embryo—ovarian cancer	0.00035	0.00709	CbGeAlD
Simvastatin—ABCC2—lymph node—ovarian cancer	0.000345	0.00699	CbGeAlD
Simvastatin—CYP2B6—testis—ovarian cancer	0.00032	0.00649	CbGeAlD
Simvastatin—CYP3A4—female reproductive system—ovarian cancer	0.0003	0.00607	CbGeAlD
Simvastatin—CYP2D6—female reproductive system—ovarian cancer	0.000295	0.00598	CbGeAlD
Simvastatin—ABCB1—epithelium—ovarian cancer	0.000286	0.00579	CbGeAlD
Simvastatin—ABCB1—uterine cervix—ovarian cancer	0.000283	0.00574	CbGeAlD
Simvastatin—ABCB1—decidua—ovarian cancer	0.00027	0.00547	CbGeAlD
Simvastatin—CYP2D6—female gonad—ovarian cancer	0.000268	0.00544	CbGeAlD
Simvastatin—ABCB1—endometrium—ovarian cancer	0.000256	0.00519	CbGeAlD
Simvastatin—CYP2D6—testis—ovarian cancer	0.000238	0.00482	CbGeAlD
Simvastatin—ABCB1—gonad—ovarian cancer	0.000238	0.00481	CbGeAlD
Simvastatin—ABCB1—uterus—ovarian cancer	0.000236	0.00478	CbGeAlD
Simvastatin—ABCB1—female reproductive system—ovarian cancer	0.000212	0.0043	CbGeAlD
Simvastatin—Purpura—Epirubicin—ovarian cancer	0.000208	0.00155	CcSEcCtD
Simvastatin—Pruritus—Melphalan—ovarian cancer	0.000207	0.00155	CcSEcCtD
Simvastatin—Vascular purpura—Doxorubicin—ovarian cancer	0.000207	0.00155	CcSEcCtD
Simvastatin—Dysgeusia—Paclitaxel—ovarian cancer	0.000206	0.00155	CcSEcCtD
Simvastatin—Hepatic failure—Doxorubicin—ovarian cancer	0.000206	0.00154	CcSEcCtD
Simvastatin—Eczema—Doxorubicin—ovarian cancer	0.000206	0.00154	CcSEcCtD
Simvastatin—Hepatitis—Docetaxel—ovarian cancer	0.000205	0.00154	CcSEcCtD
Simvastatin—Diarrhoea—Topotecan—ovarian cancer	0.000205	0.00153	CcSEcCtD
Simvastatin—Urticaria—Vinorelbine—ovarian cancer	0.000203	0.00152	CcSEcCtD
Simvastatin—Muscle spasms—Paclitaxel—ovarian cancer	0.000203	0.00152	CcSEcCtD
Simvastatin—Abdominal pain—Vinorelbine—ovarian cancer	0.000202	0.00151	CcSEcCtD
Simvastatin—Body temperature increased—Vinorelbine—ovarian cancer	0.000202	0.00151	CcSEcCtD
Simvastatin—ABCB1—bone marrow—ovarian cancer	0.0002	0.00406	CbGeAlD
Simvastatin—Diarrhoea—Melphalan—ovarian cancer	0.0002	0.0015	CcSEcCtD
Simvastatin—Nausea—Chlorambucil—ovarian cancer	0.000199	0.00149	CcSEcCtD
Simvastatin—Vision blurred—Paclitaxel—ovarian cancer	0.000199	0.00149	CcSEcCtD
Simvastatin—Dizziness—Topotecan—ovarian cancer	0.000198	0.00148	CcSEcCtD
Simvastatin—Tremor—Paclitaxel—ovarian cancer	0.000197	0.00148	CcSEcCtD
Simvastatin—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000196	0.00146	CcSEcCtD
Simvastatin—Anaemia—Paclitaxel—ovarian cancer	0.000195	0.00146	CcSEcCtD
Simvastatin—Erythema multiforme—Docetaxel—ovarian cancer	0.000194	0.00145	CcSEcCtD
Simvastatin—ABCB1—female gonad—ovarian cancer	0.000193	0.00391	CbGeAlD
Simvastatin—Angioedema—Paclitaxel—ovarian cancer	0.000193	0.00144	CcSEcCtD
Simvastatin—Purpura—Doxorubicin—ovarian cancer	0.000192	0.00144	CcSEcCtD
Simvastatin—ABCB1—vagina—ovarian cancer	0.000192	0.00389	CbGeAlD
Simvastatin—Flushing—Docetaxel—ovarian cancer	0.00019	0.00143	CcSEcCtD
Simvastatin—Vomiting—Topotecan—ovarian cancer	0.00019	0.00142	CcSEcCtD
Simvastatin—Malaise—Paclitaxel—ovarian cancer	0.00019	0.00142	CcSEcCtD
Simvastatin—Vertigo—Paclitaxel—ovarian cancer	0.000189	0.00142	CcSEcCtD
Simvastatin—Leukopenia—Paclitaxel—ovarian cancer	0.000189	0.00141	CcSEcCtD
Simvastatin—Rash—Topotecan—ovarian cancer	0.000188	0.00141	CcSEcCtD
Simvastatin—Hypersensitivity—Vinorelbine—ovarian cancer	0.000188	0.00141	CcSEcCtD
Simvastatin—Dermatitis—Topotecan—ovarian cancer	0.000188	0.00141	CcSEcCtD
Simvastatin—Headache—Topotecan—ovarian cancer	0.000187	0.0014	CcSEcCtD
Simvastatin—Vomiting—Melphalan—ovarian cancer	0.000186	0.00139	CcSEcCtD
Simvastatin—Rash—Melphalan—ovarian cancer	0.000185	0.00138	CcSEcCtD
Simvastatin—Dermatitis—Melphalan—ovarian cancer	0.000184	0.00138	CcSEcCtD
Simvastatin—Chills—Docetaxel—ovarian cancer	0.000184	0.00138	CcSEcCtD
Simvastatin—Asthenia—Vinorelbine—ovarian cancer	0.000183	0.00137	CcSEcCtD
Simvastatin—Alopecia—Docetaxel—ovarian cancer	0.000181	0.00136	CcSEcCtD
Simvastatin—Pruritus—Vinorelbine—ovarian cancer	0.000181	0.00136	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00018	0.00135	CcSEcCtD
Simvastatin—Mental disorder—Docetaxel—ovarian cancer	0.00018	0.00135	CcSEcCtD
Simvastatin—Arthralgia—Paclitaxel—ovarian cancer	0.000179	0.00134	CcSEcCtD
Simvastatin—Chest pain—Paclitaxel—ovarian cancer	0.000179	0.00134	CcSEcCtD
Simvastatin—Myalgia—Paclitaxel—ovarian cancer	0.000179	0.00134	CcSEcCtD
Simvastatin—Anxiety—Paclitaxel—ovarian cancer	0.000179	0.00134	CcSEcCtD
Simvastatin—Erythema—Docetaxel—ovarian cancer	0.000179	0.00134	CcSEcCtD
Simvastatin—Nausea—Topotecan—ovarian cancer	0.000178	0.00133	CcSEcCtD
Simvastatin—Discomfort—Paclitaxel—ovarian cancer	0.000177	0.00133	CcSEcCtD
Simvastatin—Gastritis—Epirubicin—ovarian cancer	0.000177	0.00133	CcSEcCtD
Simvastatin—Muscular weakness—Epirubicin—ovarian cancer	0.000176	0.00132	CcSEcCtD
Simvastatin—Diarrhoea—Vinorelbine—ovarian cancer	0.000175	0.00131	CcSEcCtD
Simvastatin—Dysgeusia—Docetaxel—ovarian cancer	0.000175	0.00131	CcSEcCtD
Simvastatin—Nausea—Melphalan—ovarian cancer	0.000174	0.0013	CcSEcCtD
Simvastatin—Confusional state—Paclitaxel—ovarian cancer	0.000173	0.0013	CcSEcCtD
Simvastatin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000172	0.00129	CcSEcCtD
Simvastatin—Oedema—Paclitaxel—ovarian cancer	0.000172	0.00129	CcSEcCtD
Simvastatin—Muscle spasms—Docetaxel—ovarian cancer	0.000172	0.00129	CcSEcCtD
Simvastatin—ABCB1—testis—ovarian cancer	0.000171	0.00347	CbGeAlD
Simvastatin—Eosinophilia—Epirubicin—ovarian cancer	0.000171	0.00128	CcSEcCtD
Simvastatin—Infection—Paclitaxel—ovarian cancer	0.000171	0.00128	CcSEcCtD
Simvastatin—Pancreatitis—Epirubicin—ovarian cancer	0.00017	0.00127	CcSEcCtD
Simvastatin—Dizziness—Vinorelbine—ovarian cancer	0.000169	0.00127	CcSEcCtD
Simvastatin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000168	0.00126	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000167	0.00125	CcSEcCtD
Simvastatin—Bronchitis—Epirubicin—ovarian cancer	0.000166	0.00125	CcSEcCtD
Simvastatin—Anaemia—Docetaxel—ovarian cancer	0.000165	0.00124	CcSEcCtD
Simvastatin—Anorexia—Paclitaxel—ovarian cancer	0.000164	0.00123	CcSEcCtD
Simvastatin—Gastritis—Doxorubicin—ovarian cancer	0.000164	0.00123	CcSEcCtD
Simvastatin—Muscular weakness—Doxorubicin—ovarian cancer	0.000163	0.00122	CcSEcCtD
Simvastatin—Vomiting—Vinorelbine—ovarian cancer	0.000163	0.00122	CcSEcCtD
Simvastatin—Rash—Vinorelbine—ovarian cancer	0.000161	0.00121	CcSEcCtD
Simvastatin—Dermatitis—Vinorelbine—ovarian cancer	0.000161	0.00121	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000161	0.0012	CcSEcCtD
Simvastatin—Headache—Vinorelbine—ovarian cancer	0.00016	0.0012	CcSEcCtD
Simvastatin—Leukopenia—Docetaxel—ovarian cancer	0.00016	0.0012	CcSEcCtD
Simvastatin—Eosinophilia—Doxorubicin—ovarian cancer	0.000158	0.00119	CcSEcCtD
Simvastatin—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000158	0.00118	CcSEcCtD
Simvastatin—Pancreatitis—Doxorubicin—ovarian cancer	0.000157	0.00117	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000157	0.00117	CcSEcCtD
Simvastatin—Insomnia—Paclitaxel—ovarian cancer	0.000156	0.00117	CcSEcCtD
Simvastatin—Paraesthesia—Paclitaxel—ovarian cancer	0.000154	0.00116	CcSEcCtD
Simvastatin—Bronchitis—Doxorubicin—ovarian cancer	0.000154	0.00115	CcSEcCtD
Simvastatin—Dyspnoea—Paclitaxel—ovarian cancer	0.000153	0.00115	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000153	0.00114	CcSEcCtD
Simvastatin—Arthralgia—Docetaxel—ovarian cancer	0.000152	0.00114	CcSEcCtD
Simvastatin—Myalgia—Docetaxel—ovarian cancer	0.000152	0.00114	CcSEcCtD
Simvastatin—Chest pain—Docetaxel—ovarian cancer	0.000152	0.00114	CcSEcCtD
Simvastatin—Nausea—Vinorelbine—ovarian cancer	0.000152	0.00114	CcSEcCtD
Simvastatin—Dyspepsia—Paclitaxel—ovarian cancer	0.000151	0.00113	CcSEcCtD
Simvastatin—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000151	0.00113	CcSEcCtD
Simvastatin—Jaundice—Epirubicin—ovarian cancer	0.00015	0.00113	CcSEcCtD
Simvastatin—Decreased appetite—Paclitaxel—ovarian cancer	0.00015	0.00112	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000149	0.00111	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000148	0.00111	CcSEcCtD
Simvastatin—Fatigue—Paclitaxel—ovarian cancer	0.000148	0.00111	CcSEcCtD
Simvastatin—Pain—Paclitaxel—ovarian cancer	0.000147	0.0011	CcSEcCtD
Simvastatin—Constipation—Paclitaxel—ovarian cancer	0.000147	0.0011	CcSEcCtD
Simvastatin—Confusional state—Docetaxel—ovarian cancer	0.000147	0.0011	CcSEcCtD
Simvastatin—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000146	0.00109	CcSEcCtD
Simvastatin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000146	0.00109	CcSEcCtD
Simvastatin—Oedema—Docetaxel—ovarian cancer	0.000146	0.00109	CcSEcCtD
Simvastatin—Infection—Docetaxel—ovarian cancer	0.000145	0.00108	CcSEcCtD
Simvastatin—Sinusitis—Epirubicin—ovarian cancer	0.000145	0.00108	CcSEcCtD
Simvastatin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000143	0.00107	CcSEcCtD
Simvastatin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000142	0.00106	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000141	0.00106	CcSEcCtD
Simvastatin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000141	0.00105	CcSEcCtD
Simvastatin—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.00014	0.00105	CcSEcCtD
Simvastatin—Jaundice—Doxorubicin—ovarian cancer	0.000139	0.00104	CcSEcCtD
Simvastatin—Anorexia—Docetaxel—ovarian cancer	0.000139	0.00104	CcSEcCtD
Simvastatin—Hepatitis—Epirubicin—ovarian cancer	0.000138	0.00104	CcSEcCtD
Simvastatin—Urticaria—Paclitaxel—ovarian cancer	0.000137	0.00102	CcSEcCtD
Simvastatin—Abdominal pain—Paclitaxel—ovarian cancer	0.000136	0.00102	CcSEcCtD
Simvastatin—Body temperature increased—Paclitaxel—ovarian cancer	0.000136	0.00102	CcSEcCtD
Simvastatin—Sinusitis—Doxorubicin—ovarian cancer	0.000134	0.001	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000133	0.000995	CcSEcCtD
Simvastatin—Insomnia—Docetaxel—ovarian cancer	0.000132	0.000988	CcSEcCtD
Simvastatin—Paraesthesia—Docetaxel—ovarian cancer	0.000131	0.000981	CcSEcCtD
Simvastatin—Erythema multiforme—Epirubicin—ovarian cancer	0.000131	0.00098	CcSEcCtD
Simvastatin—Dyspnoea—Docetaxel—ovarian cancer	0.00013	0.000974	CcSEcCtD
Simvastatin—Flushing—Epirubicin—ovarian cancer	0.000128	0.000962	CcSEcCtD
Simvastatin—Dyspepsia—Docetaxel—ovarian cancer	0.000128	0.000961	CcSEcCtD
Simvastatin—Hepatitis—Doxorubicin—ovarian cancer	0.000128	0.000959	CcSEcCtD
Simvastatin—Decreased appetite—Docetaxel—ovarian cancer	0.000127	0.000949	CcSEcCtD
Simvastatin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000127	0.000949	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000126	0.000943	CcSEcCtD
Simvastatin—Fatigue—Docetaxel—ovarian cancer	0.000126	0.000941	CcSEcCtD
Simvastatin—Pain—Docetaxel—ovarian cancer	0.000125	0.000934	CcSEcCtD
Simvastatin—Constipation—Docetaxel—ovarian cancer	0.000125	0.000934	CcSEcCtD
Simvastatin—Chills—Epirubicin—ovarian cancer	0.000124	0.00093	CcSEcCtD
Simvastatin—ABCB1—lymph node—ovarian cancer	0.000124	0.00251	CbGeAlD
Simvastatin—Asthenia—Paclitaxel—ovarian cancer	0.000123	0.000924	CcSEcCtD
Simvastatin—Alopecia—Epirubicin—ovarian cancer	0.000122	0.000916	CcSEcCtD
Simvastatin—Pruritus—Paclitaxel—ovarian cancer	0.000122	0.000911	CcSEcCtD
Simvastatin—Mental disorder—Epirubicin—ovarian cancer	0.000121	0.000908	CcSEcCtD
Simvastatin—Erythema multiforme—Doxorubicin—ovarian cancer	0.000121	0.000907	CcSEcCtD
Simvastatin—Erythema—Epirubicin—ovarian cancer	0.00012	0.000902	CcSEcCtD
Simvastatin—Feeling abnormal—Docetaxel—ovarian cancer	0.00012	0.0009	CcSEcCtD
Simvastatin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000119	0.000893	CcSEcCtD
Simvastatin—Flushing—Doxorubicin—ovarian cancer	0.000119	0.00089	CcSEcCtD
Simvastatin—Flatulence—Epirubicin—ovarian cancer	0.000119	0.000889	CcSEcCtD
Simvastatin—Dysgeusia—Epirubicin—ovarian cancer	0.000118	0.000884	CcSEcCtD
Simvastatin—Diarrhoea—Paclitaxel—ovarian cancer	0.000118	0.000881	CcSEcCtD
Simvastatin—Muscle spasms—Epirubicin—ovarian cancer	0.000116	0.000868	CcSEcCtD
Simvastatin—Abdominal pain—Docetaxel—ovarian cancer	0.000115	0.000863	CcSEcCtD
Simvastatin—Body temperature increased—Docetaxel—ovarian cancer	0.000115	0.000863	CcSEcCtD
Simvastatin—Chills—Doxorubicin—ovarian cancer	0.000115	0.000861	CcSEcCtD
Simvastatin—Dizziness—Paclitaxel—ovarian cancer	0.000114	0.000852	CcSEcCtD
Simvastatin—Vision blurred—Epirubicin—ovarian cancer	0.000114	0.00085	CcSEcCtD
Simvastatin—Alopecia—Doxorubicin—ovarian cancer	0.000113	0.000848	CcSEcCtD
Simvastatin—Mental disorder—Doxorubicin—ovarian cancer	0.000112	0.00084	CcSEcCtD
Simvastatin—Ill-defined disorder—Epirubicin—ovarian cancer	0.000112	0.000837	CcSEcCtD
Simvastatin—Erythema—Doxorubicin—ovarian cancer	0.000111	0.000835	CcSEcCtD
Simvastatin—Anaemia—Epirubicin—ovarian cancer	0.000111	0.000834	CcSEcCtD
Simvastatin—Flatulence—Doxorubicin—ovarian cancer	0.00011	0.000823	CcSEcCtD
Simvastatin—Vomiting—Paclitaxel—ovarian cancer	0.000109	0.000819	CcSEcCtD
Simvastatin—Dysgeusia—Doxorubicin—ovarian cancer	0.000109	0.000818	CcSEcCtD
Simvastatin—Malaise—Epirubicin—ovarian cancer	0.000109	0.000814	CcSEcCtD
Simvastatin—Rash—Paclitaxel—ovarian cancer	0.000108	0.000812	CcSEcCtD
Simvastatin—Dermatitis—Paclitaxel—ovarian cancer	0.000108	0.000812	CcSEcCtD
Simvastatin—Vertigo—Epirubicin—ovarian cancer	0.000108	0.000811	CcSEcCtD
Simvastatin—Leukopenia—Epirubicin—ovarian cancer	0.000108	0.000808	CcSEcCtD
Simvastatin—Headache—Paclitaxel—ovarian cancer	0.000108	0.000807	CcSEcCtD
Simvastatin—Hypersensitivity—Docetaxel—ovarian cancer	0.000107	0.000805	CcSEcCtD
Simvastatin—Muscle spasms—Doxorubicin—ovarian cancer	0.000107	0.000803	CcSEcCtD
Simvastatin—Vision blurred—Doxorubicin—ovarian cancer	0.000105	0.000787	CcSEcCtD
Simvastatin—Asthenia—Docetaxel—ovarian cancer	0.000105	0.000783	CcSEcCtD
Simvastatin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000103	0.000775	CcSEcCtD
Simvastatin—Pruritus—Docetaxel—ovarian cancer	0.000103	0.000773	CcSEcCtD
Simvastatin—Anaemia—Doxorubicin—ovarian cancer	0.000103	0.000772	CcSEcCtD
Simvastatin—Arthralgia—Epirubicin—ovarian cancer	0.000103	0.000768	CcSEcCtD
Simvastatin—Chest pain—Epirubicin—ovarian cancer	0.000103	0.000768	CcSEcCtD
Simvastatin—Myalgia—Epirubicin—ovarian cancer	0.000103	0.000768	CcSEcCtD
Simvastatin—Anxiety—Epirubicin—ovarian cancer	0.000102	0.000766	CcSEcCtD
Simvastatin—Nausea—Paclitaxel—ovarian cancer	0.000102	0.000765	CcSEcCtD
Simvastatin—Discomfort—Epirubicin—ovarian cancer	0.000101	0.000759	CcSEcCtD
Simvastatin—Malaise—Doxorubicin—ovarian cancer	0.000101	0.000753	CcSEcCtD
Simvastatin—Vertigo—Doxorubicin—ovarian cancer	0.0001	0.00075	CcSEcCtD
Simvastatin—Leukopenia—Doxorubicin—ovarian cancer	9.98e-05	0.000747	CcSEcCtD
Simvastatin—Diarrhoea—Docetaxel—ovarian cancer	9.97e-05	0.000747	CcSEcCtD
Simvastatin—Confusional state—Epirubicin—ovarian cancer	9.92e-05	0.000743	CcSEcCtD
Simvastatin—Anaphylactic shock—Epirubicin—ovarian cancer	9.83e-05	0.000737	CcSEcCtD
Simvastatin—Oedema—Epirubicin—ovarian cancer	9.83e-05	0.000737	CcSEcCtD
Simvastatin—Infection—Epirubicin—ovarian cancer	9.77e-05	0.000732	CcSEcCtD
Simvastatin—Dizziness—Docetaxel—ovarian cancer	9.64e-05	0.000722	CcSEcCtD
Simvastatin—Thrombocytopenia—Epirubicin—ovarian cancer	9.63e-05	0.000721	CcSEcCtD
Simvastatin—Arthralgia—Doxorubicin—ovarian cancer	9.49e-05	0.000711	CcSEcCtD
Simvastatin—Chest pain—Doxorubicin—ovarian cancer	9.49e-05	0.000711	CcSEcCtD
Simvastatin—Myalgia—Doxorubicin—ovarian cancer	9.49e-05	0.000711	CcSEcCtD
Simvastatin—Anxiety—Doxorubicin—ovarian cancer	9.46e-05	0.000708	CcSEcCtD
Simvastatin—Discomfort—Doxorubicin—ovarian cancer	9.38e-05	0.000702	CcSEcCtD
Simvastatin—Anorexia—Epirubicin—ovarian cancer	9.37e-05	0.000702	CcSEcCtD
Simvastatin—Vomiting—Docetaxel—ovarian cancer	9.27e-05	0.000694	CcSEcCtD
Simvastatin—Rash—Docetaxel—ovarian cancer	9.19e-05	0.000688	CcSEcCtD
Simvastatin—Dermatitis—Docetaxel—ovarian cancer	9.18e-05	0.000688	CcSEcCtD
Simvastatin—Confusional state—Doxorubicin—ovarian cancer	9.17e-05	0.000687	CcSEcCtD
Simvastatin—Headache—Docetaxel—ovarian cancer	9.13e-05	0.000684	CcSEcCtD
Simvastatin—Anaphylactic shock—Doxorubicin—ovarian cancer	9.1e-05	0.000681	CcSEcCtD
Simvastatin—Oedema—Doxorubicin—ovarian cancer	9.1e-05	0.000681	CcSEcCtD
Simvastatin—Infection—Doxorubicin—ovarian cancer	9.04e-05	0.000677	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	8.96e-05	0.000671	CcSEcCtD
Simvastatin—Thrombocytopenia—Doxorubicin—ovarian cancer	8.91e-05	0.000667	CcSEcCtD
Simvastatin—Insomnia—Epirubicin—ovarian cancer	8.89e-05	0.000666	CcSEcCtD
Simvastatin—Paraesthesia—Epirubicin—ovarian cancer	8.83e-05	0.000661	CcSEcCtD
Simvastatin—Dyspnoea—Epirubicin—ovarian cancer	8.77e-05	0.000657	CcSEcCtD
Simvastatin—Anorexia—Doxorubicin—ovarian cancer	8.67e-05	0.00065	CcSEcCtD
Simvastatin—Nausea—Docetaxel—ovarian cancer	8.66e-05	0.000649	CcSEcCtD
Simvastatin—Dyspepsia—Epirubicin—ovarian cancer	8.66e-05	0.000648	CcSEcCtD
Simvastatin—Decreased appetite—Epirubicin—ovarian cancer	8.55e-05	0.00064	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Epirubicin—ovarian cancer	8.49e-05	0.000636	CcSEcCtD
Simvastatin—Fatigue—Epirubicin—ovarian cancer	8.48e-05	0.000635	CcSEcCtD
Simvastatin—Pain—Epirubicin—ovarian cancer	8.41e-05	0.00063	CcSEcCtD
Simvastatin—Constipation—Epirubicin—ovarian cancer	8.41e-05	0.00063	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	8.29e-05	0.000621	CcSEcCtD
Simvastatin—Insomnia—Doxorubicin—ovarian cancer	8.23e-05	0.000616	CcSEcCtD
Simvastatin—Paraesthesia—Doxorubicin—ovarian cancer	8.17e-05	0.000612	CcSEcCtD
Simvastatin—Dyspnoea—Doxorubicin—ovarian cancer	8.11e-05	0.000608	CcSEcCtD
Simvastatin—Feeling abnormal—Epirubicin—ovarian cancer	8.1e-05	0.000607	CcSEcCtD
Simvastatin—Gastrointestinal pain—Epirubicin—ovarian cancer	8.04e-05	0.000602	CcSEcCtD
Simvastatin—Dyspepsia—Doxorubicin—ovarian cancer	8.01e-05	0.0006	CcSEcCtD
Simvastatin—Decreased appetite—Doxorubicin—ovarian cancer	7.91e-05	0.000592	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	7.86e-05	0.000588	CcSEcCtD
Simvastatin—Fatigue—Doxorubicin—ovarian cancer	7.84e-05	0.000588	CcSEcCtD
Simvastatin—Urticaria—Epirubicin—ovarian cancer	7.81e-05	0.000585	CcSEcCtD
Simvastatin—Constipation—Doxorubicin—ovarian cancer	7.78e-05	0.000583	CcSEcCtD
Simvastatin—Pain—Doxorubicin—ovarian cancer	7.78e-05	0.000583	CcSEcCtD
Simvastatin—Abdominal pain—Epirubicin—ovarian cancer	7.77e-05	0.000582	CcSEcCtD
Simvastatin—Body temperature increased—Epirubicin—ovarian cancer	7.77e-05	0.000582	CcSEcCtD
Simvastatin—Feeling abnormal—Doxorubicin—ovarian cancer	7.5e-05	0.000562	CcSEcCtD
Simvastatin—Gastrointestinal pain—Doxorubicin—ovarian cancer	7.44e-05	0.000557	CcSEcCtD
Simvastatin—Hypersensitivity—Epirubicin—ovarian cancer	7.24e-05	0.000543	CcSEcCtD
Simvastatin—Urticaria—Doxorubicin—ovarian cancer	7.23e-05	0.000541	CcSEcCtD
Simvastatin—Body temperature increased—Doxorubicin—ovarian cancer	7.19e-05	0.000539	CcSEcCtD
Simvastatin—Abdominal pain—Doxorubicin—ovarian cancer	7.19e-05	0.000539	CcSEcCtD
Simvastatin—Asthenia—Epirubicin—ovarian cancer	7.06e-05	0.000528	CcSEcCtD
Simvastatin—Pruritus—Epirubicin—ovarian cancer	6.96e-05	0.000521	CcSEcCtD
Simvastatin—Diarrhoea—Epirubicin—ovarian cancer	6.73e-05	0.000504	CcSEcCtD
Simvastatin—Hypersensitivity—Doxorubicin—ovarian cancer	6.7e-05	0.000502	CcSEcCtD
Simvastatin—Asthenia—Doxorubicin—ovarian cancer	6.53e-05	0.000489	CcSEcCtD
Simvastatin—Dizziness—Epirubicin—ovarian cancer	6.5e-05	0.000487	CcSEcCtD
Simvastatin—Pruritus—Doxorubicin—ovarian cancer	6.44e-05	0.000482	CcSEcCtD
Simvastatin—Vomiting—Epirubicin—ovarian cancer	6.25e-05	0.000468	CcSEcCtD
Simvastatin—Diarrhoea—Doxorubicin—ovarian cancer	6.23e-05	0.000466	CcSEcCtD
Simvastatin—Rash—Epirubicin—ovarian cancer	6.2e-05	0.000464	CcSEcCtD
Simvastatin—Dermatitis—Epirubicin—ovarian cancer	6.19e-05	0.000464	CcSEcCtD
Simvastatin—Headache—Epirubicin—ovarian cancer	6.16e-05	0.000461	CcSEcCtD
Simvastatin—Dizziness—Doxorubicin—ovarian cancer	6.02e-05	0.000451	CcSEcCtD
Simvastatin—Nausea—Epirubicin—ovarian cancer	5.84e-05	0.000437	CcSEcCtD
Simvastatin—Vomiting—Doxorubicin—ovarian cancer	5.79e-05	0.000433	CcSEcCtD
Simvastatin—Rash—Doxorubicin—ovarian cancer	5.74e-05	0.00043	CcSEcCtD
Simvastatin—Dermatitis—Doxorubicin—ovarian cancer	5.73e-05	0.000429	CcSEcCtD
Simvastatin—Headache—Doxorubicin—ovarian cancer	5.7e-05	0.000427	CcSEcCtD
Simvastatin—Nausea—Doxorubicin—ovarian cancer	5.4e-05	0.000405	CcSEcCtD
Simvastatin—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.7e-05	0.000233	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—BRIP1—ovarian cancer	1.7e-05	0.000233	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PPP1CC—ovarian cancer	1.7e-05	0.000233	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.7e-05	0.000232	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.69e-05	0.000232	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CYTB—ovarian cancer	1.69e-05	0.000232	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PIK3CG—ovarian cancer	1.69e-05	0.000232	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.69e-05	0.000232	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—SLC2A1—ovarian cancer	1.68e-05	0.000229	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.66e-05	0.000227	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.64e-05	0.000225	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—ABCB1—ovarian cancer	1.63e-05	0.000223	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—NME2—ovarian cancer	1.62e-05	0.000222	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—FASN—ovarian cancer	1.62e-05	0.000221	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.61e-05	0.000221	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—CYP1B1—ovarian cancer	1.61e-05	0.00022	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—TYMS—ovarian cancer	1.6e-05	0.000219	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.6e-05	0.000219	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CYTB—ovarian cancer	1.59e-05	0.000218	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	1.59e-05	0.000218	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CYTB—ovarian cancer	1.58e-05	0.000217	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.56e-05	0.000213	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.55e-05	0.000212	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	1.53e-05	0.00021	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PPP2R1A—ovarian cancer	1.53e-05	0.000209	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.52e-05	0.000208	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—BRIP1—ovarian cancer	1.52e-05	0.000208	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PPP1CC—ovarian cancer	1.52e-05	0.000208	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—CAV1—ovarian cancer	1.51e-05	0.000207	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.5e-05	0.000206	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PIK3CD—ovarian cancer	1.49e-05	0.000204	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—FASN—ovarian cancer	1.48e-05	0.000203	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—BRIP1—ovarian cancer	1.48e-05	0.000203	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.48e-05	0.000203	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	1.47e-05	0.000202	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—SLC5A5—ovarian cancer	1.46e-05	0.0002	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PPP2R1A—ovarian cancer	1.42e-05	0.000195	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—ABCB1—ovarian cancer	1.42e-05	0.000194	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—SLC2A1—ovarian cancer	1.41e-05	0.000193	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.41e-05	0.000193	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PPP1CC—ovarian cancer	1.39e-05	0.000191	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—BRIP1—ovarian cancer	1.39e-05	0.000191	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—TYMS—ovarian cancer	1.39e-05	0.000191	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.38e-05	0.000189	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.38e-05	0.000189	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PIK3CG—ovarian cancer	1.38e-05	0.000189	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CYP1B1—ovarian cancer	1.35e-05	0.000185	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—YAP1—ovarian cancer	1.35e-05	0.000184	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.33e-05	0.000182	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—ABCB1—ovarian cancer	1.32e-05	0.000181	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—YAP1—ovarian cancer	1.31e-05	0.00018	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	1.31e-05	0.000179	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—TYMS—ovarian cancer	1.3e-05	0.000178	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.3e-05	0.000178	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PIK3CB—ovarian cancer	1.3e-05	0.000178	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.29e-05	0.000177	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—CAV1—ovarian cancer	1.29e-05	0.000176	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.27e-05	0.000173	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.27e-05	0.000173	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.24e-05	0.000169	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PIK3CD—ovarian cancer	1.21e-05	0.000166	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—ABCB1—ovarian cancer	1.21e-05	0.000166	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	1.2e-05	0.000164	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.2e-05	0.000164	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—TYMS—ovarian cancer	1.19e-05	0.000163	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PIK3CG—ovarian cancer	1.17e-05	0.000161	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—YAP1—ovarian cancer	1.14e-05	0.000156	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.13e-05	0.000154	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—CAV1—ovarian cancer	1.12e-05	0.000154	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PTEN—ovarian cancer	1.12e-05	0.000153	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—ABCB1—ovarian cancer	1.11e-05	0.000152	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.1e-05	0.000151	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.1e-05	0.00015	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—FASN—ovarian cancer	1.1e-05	0.00015	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—TYMS—ovarian cancer	1.09e-05	0.00015	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—SLC5A5—ovarian cancer	1.08e-05	0.000148	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—FASN—ovarian cancer	1.07e-05	0.000147	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.07e-05	0.000147	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.06e-05	0.000146	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PIK3CB—ovarian cancer	1.06e-05	0.000145	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.05e-05	0.000144	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—CAV1—ovarian cancer	1.05e-05	0.000143	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CYTB—ovarian cancer	1.04e-05	0.000143	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—SLC2A1—ovarian cancer	1.04e-05	0.000143	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PIK3CD—ovarian cancer	1.03e-05	0.000141	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	1.02e-05	0.00014	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—SLC2A1—ovarian cancer	1.02e-05	0.000139	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—YAP1—ovarian cancer	1.02e-05	0.000139	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.01e-05	0.000138	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.01e-05	0.000138	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CYP1B1—ovarian cancer	9.99e-06	0.000137	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—YAP1—ovarian cancer	9.92e-06	0.000136	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.91e-06	0.000136	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CYP1B1—ovarian cancer	9.76e-06	0.000134	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—CAV1—ovarian cancer	9.59e-06	0.000131	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PIK3CG—ovarian cancer	9.53e-06	0.000131	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—YAP1—ovarian cancer	9.35e-06	0.000128	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—FASN—ovarian cancer	9.28e-06	0.000127	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—YAP1—ovarian cancer	9.27e-06	0.000127	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.17e-06	0.000126	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.16e-06	0.000125	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PTEN—ovarian cancer	9.14e-06	0.000125	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—SLC5A5—ovarian cancer	9.13e-06	0.000125	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—BRIP1—ovarian cancer	9.11e-06	0.000125	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PPP1CC—ovarian cancer	9.11e-06	0.000125	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PIK3CB—ovarian cancer	8.99e-06	0.000123	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	8.98e-06	0.000123	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	8.97e-06	0.000123	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	8.86e-06	0.000121	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.84e-06	0.000121	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—SLC2A1—ovarian cancer	8.82e-06	0.000121	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CAV1—ovarian cancer	8.8e-06	0.000121	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	8.74e-06	0.00012	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	8.66e-06	0.000119	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.64e-06	0.000118	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CYP1B1—ovarian cancer	8.46e-06	0.000116	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PIK3CD—ovarian cancer	8.38e-06	0.000115	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—FASN—ovarian cancer	8.29e-06	0.000113	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—ABCB1—ovarian cancer	8.23e-06	0.000113	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—SLC5A5—ovarian cancer	8.15e-06	0.000112	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—FASN—ovarian cancer	8.09e-06	0.000111	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—TYMS—ovarian cancer	8.08e-06	0.000111	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.06e-06	0.00011	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—ABCB1—ovarian cancer	8.04e-06	0.00011	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PIK3CG—ovarian cancer	8.02e-06	0.00011	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—SLC5A5—ovarian cancer	7.96e-06	0.000109	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PIK3CA—ovarian cancer	7.91e-06	0.000108	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—TYMS—ovarian cancer	7.9e-06	0.000108	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—SLC2A1—ovarian cancer	7.87e-06	0.000108	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	7.83e-06	0.000107	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PTEN—ovarian cancer	7.77e-06	0.000106	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.71e-06	0.000106	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—SLC2A1—ovarian cancer	7.68e-06	0.000105	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	7.68e-06	0.000105	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—FASN—ovarian cancer	7.62e-06	0.000104	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—FASN—ovarian cancer	7.56e-06	0.000103	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CYP1B1—ovarian cancer	7.55e-06	0.000103	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	7.5e-06	0.000103	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—SLC5A5—ovarian cancer	7.5e-06	0.000103	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.46e-06	0.000102	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—SLC5A5—ovarian cancer	7.43e-06	0.000102	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CYP1B1—ovarian cancer	7.37e-06	0.000101	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PIK3CB—ovarian cancer	7.3e-06	0.0001	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—SLC2A1—ovarian cancer	7.24e-06	9.92e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—SLC2A1—ovarian cancer	7.18e-06	9.83e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PIK3CD—ovarian cancer	7.05e-06	9.65e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.03e-06	9.63e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—ABCB1—ovarian cancer	6.96e-06	9.54e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CYP1B1—ovarian cancer	6.94e-06	9.51e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CYP1B1—ovarian cancer	6.88e-06	9.42e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—TYMS—ovarian cancer	6.84e-06	9.36e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PTEN—ovarian cancer	6.76e-06	9.26e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	6.69e-06	9.17e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	6.69e-06	9.17e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.66e-06	9.12e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PPP2R1A—ovarian cancer	6.53e-06	8.95e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CAV1—ovarian cancer	6.51e-06	8.91e-05	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—AKT1—ovarian cancer	6.46e-06	8.84e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PIK3CA—ovarian cancer	6.44e-06	8.82e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CAV1—ovarian cancer	6.36e-06	8.71e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PTEN—ovarian cancer	6.31e-06	8.64e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ABCB1—ovarian cancer	6.22e-06	8.51e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	6.16e-06	8.43e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PIK3CB—ovarian cancer	6.14e-06	8.41e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—YAP1—ovarian cancer	6.11e-06	8.37e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—TYMS—ovarian cancer	6.1e-06	8.36e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	6.1e-06	8.36e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.07e-06	8.32e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—TYMS—ovarian cancer	5.96e-06	8.16e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PIK3CG—ovarian cancer	5.93e-06	8.12e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PIK3CG—ovarian cancer	5.8e-06	7.94e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PTEN—ovarian cancer	5.78e-06	7.92e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ABCB1—ovarian cancer	5.72e-06	7.83e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ABCB1—ovarian cancer	5.67e-06	7.76e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—TYMS—ovarian cancer	5.61e-06	7.69e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—TYMS—ovarian cancer	5.57e-06	7.62e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CAV1—ovarian cancer	5.51e-06	7.55e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PIK3CA—ovarian cancer	5.48e-06	7.5e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PTEN—ovarian cancer	5.31e-06	7.27e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.27e-06	7.21e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—AKT1—ovarian cancer	5.26e-06	7.21e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PIK3CD—ovarian cancer	5.21e-06	7.14e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PIK3CD—ovarian cancer	5.09e-06	6.98e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PIK3CG—ovarian cancer	5.02e-06	6.87e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—FASN—ovarian cancer	4.98e-06	6.82e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CAV1—ovarian cancer	4.92e-06	6.74e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.9e-06	6.71e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CAV1—ovarian cancer	4.8e-06	6.57e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	4.77e-06	6.53e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—SLC2A1—ovarian cancer	4.73e-06	6.48e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.7e-06	6.43e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PIK3CB—ovarian cancer	4.54e-06	6.22e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CYP1B1—ovarian cancer	4.54e-06	6.22e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CAV1—ovarian cancer	4.52e-06	6.2e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CAV1—ovarian cancer	4.49e-06	6.14e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PIK3CG—ovarian cancer	4.48e-06	6.14e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—AKT1—ovarian cancer	4.48e-06	6.13e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PIK3CA—ovarian cancer	4.45e-06	6.1e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PIK3CB—ovarian cancer	4.44e-06	6.08e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PIK3CD—ovarian cancer	4.41e-06	6.04e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PIK3CG—ovarian cancer	4.37e-06	5.99e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.29e-06	5.87e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PIK3CG—ovarian cancer	4.12e-06	5.64e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PIK3CG—ovarian cancer	4.09e-06	5.59e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	4.08e-06	5.59e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.03e-06	5.51e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PIK3CD—ovarian cancer	3.94e-06	5.39e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PTEN—ovarian cancer	3.93e-06	5.38e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—AKT1—ovarian cancer	3.9e-06	5.34e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PIK3CB—ovarian cancer	3.85e-06	5.27e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.84e-06	5.26e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PTEN—ovarian cancer	3.84e-06	5.25e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PIK3CA—ovarian cancer	3.75e-06	5.13e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.74e-06	5.12e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—TYMS—ovarian cancer	3.67e-06	5.03e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—AKT1—ovarian cancer	3.64e-06	4.98e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PIK3CD—ovarian cancer	3.62e-06	4.96e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PIK3CD—ovarian cancer	3.59e-06	4.92e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PIK3CB—ovarian cancer	3.43e-06	4.7e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.35e-06	4.59e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—AKT1—ovarian cancer	3.33e-06	4.56e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PTEN—ovarian cancer	3.32e-06	4.55e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PIK3CB—ovarian cancer	3.16e-06	4.32e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PIK3CB—ovarian cancer	3.13e-06	4.29e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—AKT1—ovarian cancer	3.06e-06	4.19e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PTEN—ovarian cancer	2.97e-06	4.06e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CAV1—ovarian cancer	2.96e-06	4.05e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PTEN—ovarian cancer	2.9e-06	3.96e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PIK3CA—ovarian cancer	2.77e-06	3.79e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PTEN—ovarian cancer	2.73e-06	3.74e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PIK3CA—ovarian cancer	2.71e-06	3.71e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PTEN—ovarian cancer	2.71e-06	3.7e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.69e-06	3.69e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.37e-06	3.24e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.34e-06	3.21e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—AKT1—ovarian cancer	2.26e-06	3.1e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—AKT1—ovarian cancer	2.21e-06	3.03e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.09e-06	2.87e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.06e-06	2.83e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.04e-06	2.8e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.92e-06	2.64e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—AKT1—ovarian cancer	1.92e-06	2.62e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.91e-06	2.61e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PTEN—ovarian cancer	1.78e-06	2.44e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—AKT1—ovarian cancer	1.71e-06	2.34e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—AKT1—ovarian cancer	1.67e-06	2.29e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—AKT1—ovarian cancer	1.57e-06	2.15e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—AKT1—ovarian cancer	1.56e-06	2.13e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.26e-06	1.72e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—AKT1—ovarian cancer	1.03e-06	1.41e-05	CbGpPWpGaD
